XML 38 R26.htm IDEA: XBRL DOCUMENT v3.25.1
Income Taxes
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Income Taxes

Note 14. Income Taxes

Components of Income Before Taxes

For financial reporting purposes, income before income taxes includes the following components (in thousands):

 

Year ended December 31,

 

 

2024

 

 

2023

 

 

2022

 

Domestic

 

$

(152,496

)

 

$

(149,540

)

 

$

(147,314

)

Foreign

 

 

406

 

 

 

207

 

 

 

9

 

Income (loss) before income taxes

 

$

(152,090

)

 

$

(149,333

)

 

$

(147,305

)

 

Components of Tax Expense

The components of income tax expense are as follows (in thousands):

 

 

Year ended December 31,

 

 

2024

 

 

2023

 

Current:

 

 

 

 

 

 

Federal

 

$

 

 

$

 

State

 

 

 

 

 

 

Foreign

 

 

171

 

 

 

 

Total Current

 

 

171

 

 

 

 

Deferred:

 

 

 

 

 

 

Federal

 

 

 

 

 

 

State

 

 

 

 

 

 

Foreign

 

 

 

 

 

 

Total Deferred

 

$

 

 

$

 

 

Reconciliation between the effective tax rate on income from continuing operations and the statutory tax rate of 21% is as follows:

 

Year ended December 31,

 

 

2024

 

 

2023

 

 

2022

 

U.S. federal provision at statutory rate

 

 

21.0

%

 

 

21.0

%

 

 

21.0

%

Tax credits

 

 

2.6

%

 

 

3.0

%

 

 

2.7

%

Stock-based compensation

 

 

(2.2

)%

 

 

(2.7

)%

 

 

1.9

%

Section 162(m)

 

 

(0.7

)%

 

 

(0.1

)%

 

 

(0.6

)%

Change in valuation allowance

 

 

(20.2

)%

 

 

(19.6

)%

 

 

(25.1

)%

Other

 

 

(0.5

)%

 

 

(1.6

)%

 

 

0.1

%

Effective tax rate

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

 

The Company’s effective tax rates differ from the federal statutory rate primarily due to the change in valuation allowance.

Deferred Taxes

The Company’s deferred income tax assets and liabilities as of December 31, 2024 and 2023 were as follows (in thousands):

 

Year ended December 31,

 

 

2024

 

 

2023

 

Deferred tax assets:

 

 

 

 

 

 

Net operating loss carry forward

 

$

79,991

 

 

$

62,346

 

Tax credits

 

 

24,293

 

 

 

18,261

 

Intangibles

 

 

3,535

 

 

 

3,499

 

Other

 

 

(1

)

 

 

28

 

Stock-based compensation

 

 

1,880

 

 

 

1,998

 

Lease liability

 

 

827

 

 

 

1,542

 

Research and development costs

 

 

47,018

 

 

 

33,341

 

Fixed assets

 

 

37

 

 

 

 

Accruals and reserves

 

 

1,384

 

 

 

1,364

 

Total deferred tax assets before valuation allowance

 

 

158,964

 

 

 

122,379

 

Valuation allowance

 

 

(158,121

)

 

 

(120,779

)

Total deferred tax assets

 

 

843

 

 

 

1,600

 

Deferred tax liabilities:

 

 

 

 

 

 

Right of use assets

 

 

(843

)

 

 

(1,528

)

Fixed assets

 

 

 

 

 

(72

)

Total deferred tax liabilities

 

 

(843

)

 

 

(1,600

)

Net deferred tax assets (liabilities)

 

$

 

 

$

 

 

The Company assesses the realizability of deferred tax assets based on the available evidence, including a history of taxable income and estimates of future taxable income. In assessing the realizability of deferred tax assets, the Company considers whether it is more likely than not that all or some portion of deferred tax assets will not be realized. Due to the losses the Company generated in the current and prior years; the Company believes it is not more likely than not that all of the deferred tax assets can be realized. Accordingly, the Company established and recorded a full valuation allowance on its net deferred tax assets of $158.1 million as of December 31, 2024 and a net valuation allowance on its deferred tax assets of $120.8 million as of December 31, 2023. The valuation allowance increased by $37.3 million for the year ended December 31, 2024.

 

As a result of the Tax Cuts and Jobs Act (the “Tax Act”), foreign accumulated earnings that were subject to the mandatory transition tax as of December 31, 2017, can be repatriated to the U.S. without incurring further U.S. federal tax. The Tax Act moves towards a modified territorial tax system through the provision of a 100% dividend received deduction for the foreign-source portions of dividends received from controlled foreign subsidiaries. As a result, the Company continues to evaluate the indefinite reinvestment assertions with regards to unremitted earnings for our foreign subsidiaries. As of December 31, 2024 the total undistributed earnings of the Company’s foreign subsidiaries were approximately $0.2 million. The Company has asserted its intention to indefinitely reinvest the undistributed earnings of foreign subsidiaries. The unrecognized deferred tax liability on the portion of the undistributed earnings considered indefinitely reinvested is not material.

As of December 31, 2024, the Company had $308.7 million of U.S. federal and $230.5 million of state net operating loss carryforwards available to reduce future taxable income, of which $305.5 million will be carried forward indefinitely for U.S. federal tax purposes and the remainder of losses will expire beginning in 2036 for federal and 2031 for state tax purposes.

The Company also has federal and California research and development tax credit carryforwards of $27.7 million and $18.0 million, respectively. The federal research credit carryforwards will expire in 2036 and California research credits can be carried forward indefinitely.

The federal and state net operating loss carryforwards may be subject to significant limitations under Section 382 and Section 383 of the Internal Revenue Code of 1986, as amended, and similar provisions under state law. The Tax Reform Act of 1986 contains provisions that limit the federal net operating loss carryforwards that may be used

in any given year in the event of special occurrences, including significant ownership changes. The Company has completed analysis as of December 31, 2024 and doesn’t expect any net operating loss carryforwards or tax credit carryforwards to expire due to a limitation.

Unrecognized Tax Benefits

The Company accrues for uncertain tax positions identified, which are not deemed more likely than not to be sustained if challenged, and recognizes interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. The Company has not accrued any interest on uncertain tax benefits associated with unrecognized tax benefits and had immaterial cumulative interest and penalties as of December 31, 2024, 2023 and 2022.

The Company does not expect that the total amounts of unrecognized tax benefits will significantly increase or decrease within 12 months of the reporting date.

The following is a tabular reconciliation of the total amounts of unrecognized tax benefits (in thousands):

 

Year ended December 31,

 

 

2024

 

 

2023

 

 

2022

 

Unrecognized tax benefits as of the beginning of the year

 

$

13,809

 

 

$

8,872

 

 

$

4,702

 

Increase related to prior year tax provisions

 

 

111

 

 

 

 

 

 

(100

)

Decrease related to prior year tax provisions

 

 

 

 

 

 

 

 

 

Increase related to current year tax provisions

 

 

4,397

 

 

 

4,937

 

 

 

4,270

 

Statue lapse

 

 

 

 

 

 

 

 

 

Unrecognized tax benefits as of the end of the year

 

$

18,317

 

 

$

13,809

 

 

$

8,872

 

 

There are no amounts included in the balance of unrecognized tax benefits as of December 31, 2024, 2023 and 2022, that, if recognized, would affect the effective tax rate.

The Company’s major tax jurisdictions are the United States, various states and India. Due to the net operating loss carryforward since inception, all tax years are open for examination. There have been no examinations of the Company’s income tax returns by any tax authority.